# Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency

> **NCT00745316** · PHASE2 · TERMINATED · sponsor: **Biogen** · enrollment: 34 (actual)

## Conditions studied

- Renal Insufficiency
- Heart Failure

## Interventions

- **DRUG:** Tonapofylline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00745316
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Company Decision
- **Last updated:** 2023-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00745316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00745316, "Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00745316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*